{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ATC|NERVOUS SYSTEM|OTHER NERVOUS SYSTEM DRUGS|PARASYMPATHOMIMETICS|Choline esters" in comments (approximate match)
Showing 1 - 2 of 2 results
Status:
US Approved Rx
(2007)
Source:
ANDA040855
(2007)
Source URL:
First approved in 1948
Source:
URECHOLINE by TEVA BRANDED PHARM
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Conditions:
Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors with little effect on nicotinic receptors. Bethanechol is indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
Status:
US Approved Rx
(1972)
Source:
NDA016968
(1972)
Source URL:
First approved in 1972
Source:
NDA016968
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure.